AffyXell Therapeutics develops novel mesenchymal stem cell therapies. Founded in 2020, AffyXell Therapeutics is backed by investors that include Smilegate Investment, Samsung Venture Investment, Stonebridge Ventures, Shinhan Investment Corporation, and Kolon Investment and is headquartered in .